Arrhythmias & electrophysiology

Concurrent vs Staged Hybrid Ablation for Long-Standing Persistent Atrial Fibrillation: A Propensity-Matched Cohort Study

JACC Clin ElectrophysiolPublished Matched cohort study

Authors' conclusion

Both concurrent and staged hybrid ablation could be safely and effectively applied to treat LSPAF.

Study context

Population
Patients with long-standing persistent atrial fibrillation (AF), December 2015 to December 2021matched 1:1
Participants
104 patients
Exposure
Concurrent vs staged minimally invasive surgical-catheter hybrid ablation
Outcome
Freedom from AF or AT off antiarrhythmic drugs
Follow-up
2 years after hybrid ablation

Main finding

As reported in the abstract

2 years

P = 0.390

Observational data: associations, not effects.

Further findings

Intraprocedural AF termination (Concurrent) / AF or AT termination during staged catheter ablation (CA) (Staged) — Concurrent
86.5%
  • Intraprocedural AF termination (Concurrent) / AF or AT termination during staged CA (Staged): Staged: all 52 underwent staged CA for recurrent AF or AT

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Concurrent vs Staged Hybrid Ablation for Long-Standing Persistent Atrial Fibrillation: A Propensity-Matched Cohort Study. JACC Clin Electrophysiol. Published 3 April 2024. doi:10.1016/j.jacep.2024.02.017

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.